Clinical Trials Browser

Adenocarcinoma × tislelizumab × Gastrointestinal × Clear all

NCT04363801 2025-10-09

DisTinGuish

Phase 2 Terminated

247 enrolled 38 charts

Gastrointestinal

Adenocarcinoma, Neoplasms, Stomach Neoplasms

NCT05604560 2025-07-23

A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer

Phase 2 Active not recruiting

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms